The molecular characteristics of primary and metastatic tumors in patients with upper tract urothelial carcinoma (UTUC) are mostly stable, suggesting that oncologists may be able to use analyses of primary tumor samples for molecular...
The molecular characteristics of primary and metastatic tumors in patients with upper tract urothelial carcinoma (UTUC) are mostly stable, suggesting that oncologists may be able to use analyses of primary tumor samples for molecular...
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and...
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and...
Recent data has established enfortumab vedotin (EV) and pembrolizumab (P) as the preferred first-line (1L) treatment option for patients with metastatic urothelial cancer, according to an article in American Society of Clinical Oncology...
Recent data has established enfortumab vedotin (EV) and pembrolizumab (P) as the preferred first-line (1L) treatment option for patients with metastatic urothelial cancer, according to an article in American Society of Clinical Oncology...
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
“In this study, we sought to systematically compare current international guidelines and recommendations and to identify both discrepancies and similarities regarding the management of UTUC,” wrote researchers.
“In this study, we sought to systematically compare current international guidelines and recommendations and to identify both discrepancies and similarities regarding the management of UTUC,” wrote researchers.
This literature review explores key data related to the epidemiology, clinical presentation, and treatment considerations for patients with low-grade upper tract urothelial carcinoma.
This literature review explores key data related to the epidemiology, clinical presentation, and treatment considerations for patients with low-grade upper tract urothelial carcinoma.
The agency’s request for a review of the approvals process for the monoclonal antibody aducanumab is the latest twist in an unprecedented saga involving the Alzheimer disease treatment. We asked a panel of experts to analyze the approvals...
The agency’s request for a review of the approvals process for the monoclonal antibody aducanumab is the latest twist in an unprecedented saga involving the Alzheimer disease treatment. We asked a panel of experts to analyze the approvals...
